Innovation Pharmaceuticals Inc (IPIX)

[TOB]

Days away from Brilacidin-OM NEW Clinical Trial update.

A week from tomorrow marks 30 days from IND submission.

Once the applicant has submitted a complete response to the clinical hold, the Agency must evaluate the response and decide whether to lift the hold. The Agency has committed itself to respond to the applicant within 30 days-Link

Yes, another Phase 2 Brilacidin trial, Brilacidin-OM could be starting just as the current Brilacidin-ABSSSI Phase 2b trial issues top line data.

IMO:

1. The IND for Bilacidin justifies a larger CTIX rally than what we've seen so far.

2. The Pre-Catalyst rally for the soon to be un-blinded Brilacidin-ABSSI p2b justifies a larger rally than we've seen to date.

3. The Kevetrin Phase 1 Clinical Trial entering a new cohort at a significantly higher dose, well past the the dosing level believed therapeutic, and an almost certain successful clinical trial primary outcome measure, justifies a larger rally than we've seen to date.

4. The new Kevetrin Phase 1b Clinical Trial as a combination therapy for Leukemia (AML) is expected to start this year, which justifies a larger rally than we've seen to date.

5. Let's not forget Prurisol, coming soon to a Phase 2/3 Clinical Trial, which also justifies a larger rally than we've seen to date.

6. Up-Listing plans, financing already in place for up-coming trials, and a strong possibility of a partnership on positive Brilacidin P2b results. -Link to 10-K which justifies a larger rally than we've seen to date.

Brilacidin has proven efficacy and safety, and the safety and efficacy profile of the now concluded trial appears even better. Top Line results will give the facts.

There is always risk, but each of these trial serves as a safety net for the others, significantly de-risking CTIX IMO.

A medical doctor has posted that Brilacidin-OM is gaining serious interest from the medical community. Let's keep in mind that while the current Brilacidin-ABSSSI trial improves on existing therapies, the Brilacidin-OM addresses a horrible and common condition for which there is NO effective existing therapy.